Tenormin (atenolol) is a small molecule pharmaceutical. Atenolol was first approved as Tenormin on 1982-01-01. It is used to treat angina pectoris, atrial fibrillation, atrial flutter, heart failure, and hypertension amongst others in the USA. The pharmaceutical is active against beta-1 adrenergic receptor. In addition, it is known to target beta-2 adrenergic receptor and Basic phospholipase A2 VRV-PL-VIIIa.
|Indication||angina pectoris, atrial fibrillation, atrial flutter, heart failure, hypertension, myocardial infarction, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia|
|Drug Class||Beta-blockers (propranolol type)|